IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,615,992 | +63.1% | 66,497 | +0.9% | 0.02% | +45.5% |
| Q1 2023 | $1,603,688 | +17.7% | 65,914 | +3.6% | 0.01% | +10.0% |
| Q4 2022 | $1,362,789 | +35.1% | 63,652 | +13.1% | 0.01% | +42.9% |
| Q3 2022 | $1,009,000 | +91.8% | 56,262 | +2.9% | 0.01% | +75.0% |
| Q2 2022 | $526,000 | -45.3% | 54,688 | -4.3% | 0.00% | -20.0% |
| Q1 2022 | $961,000 | -6.0% | 57,119 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $1,022,000 | +10.1% | 61,140 | +7.0% | 0.01% | 0.0% |
| Q3 2021 | $928,000 | +190.0% | 57,128 | +12.6% | 0.01% | +400.0% |
| Q2 2021 | $320,000 | +10.7% | 50,752 | +8.4% | 0.00% | 0.0% |
| Q1 2021 | $289,000 | -10.5% | 46,821 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $323,000 | +19.2% | 46,697 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $271,000 | +92.2% | 48,037 | +74.1% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | – | 27,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |